Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Updated prezzie

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon May 21, 2024 4:48pm

164 Views

Post# 36050778

RE:RE:RE:RE:RE:Updated prezzie

I agree that that the 50% (+\~) of the margin that they don't control is much juicier. It doesn't come with all those pesky expenses like marketing and distribution and operations. Mind you, the owners had to spend > $ 100M to reserve the juicy part.

I would venture to say that nothing on the kidney side brings margins anywhere close to PMX.

MM

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement